Posted AT 4:51 PM EST on 19/07/06
FDA warns of risks of antidepressants during pregnancy
WASHINGTON — The manufacturers of Prozac and other antidepressants should include prescribing information about an uncommon but life-threatening lung problem that affects babies born to mothers who take the drugs during pregnancy, health officials said Wednesday.
The U.S. Food and Drug Administration said it had asked the companies to add information about the possible risk of the lung disorder, called persistent pulmonary hypertension.
The full text of this article has 281 words.
To continue reading this article, you will need to purchase this article.
Already have a member account? Login now
Pay-Per-View Offers To read the complete article, select one of the following options
Purchasing from globeandmail.com is quick and secure.
Video 
- Life on the scale
- Last July, Juliann Sliwa walked into the Wharton Medical Clinic, weighing 481 pounds. Her goals: To cross her legs. To tie her shoes. To dance. To live past 47. Reporter Hayley Mick and photographer Kevin Van Paassen document a year of struggle
40
-
Discussion:
Experts take questions on losing weight
In Focus
- Childhood obesity
- The Canadian founder of California's private Wellspring Academy claims to have the formula to battle the skyrocketing problem of overweight children
58
Breakdown
- Our mental health crisis
- Globe series tackles stigma, tells stories of Canadians
Earlier discussion
slideshow
- Medical marijuna
- Alison Myrden's painful battle with MS
Features
- Confronting cancer
- Globe Series concludes with look at people who blaze trails
- Battling cancer
- Breast cancer death rates declining
-
Special report:
A day in the life
In pictures
- Best position in bed
- How you sleep can make you feel better or worse
